Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
69.00
Ask:
71.00
Spread: 2.00 (2.899%)
Market Cap: £61.65m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Result of EGM-Replacement

2 Jul 2007 17:36

Calyx Group PLC02 July 2007 Correction - In the Result of EGM announcement released today (RNS 4875Z), thedate of the three meetings was incorrect. The date of the three meetings wasMonday 2 July 2007 and has been correctly disclosed in the announcement below.No other changes have been made to this announcement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO ORFROM ANY RESTRICTED JURISDICTION Calyx Group plc ("Calyx" or the "Company") Result of Court Meetings and EGM The First Court Meeting was held on Monday, 2 July 2007 to enable CalyxShareholders (other than the Stornoway Class Shareholders) to consider and, ifthought fit, approve the Scheme. The resolution was decided on a poll and theresolution proposed was passed. The number of votes for and against theresolution were as follows: Shares Shareholders (either in person or by proxy) Number % Number %For 31,453,240 99.99% 48 98%Against 1,000 N/A 1 2% The Second Court Meeting was held on Monday, 2 July 2007 to enable StornowayClass Shareholders to consider and, if thought fit, approve the Scheme. Theresolution was decided on a poll and the resolution proposed was passed. Thenumber of votes for and against the resolution were as follows: Shares Shareholders (either in person or by proxy) Number % Number %For 21,419,738 100% 3 100%Against - - - - An Extraordinary General Meeting was held on Monday, 2 July 07 and allresolutions proposed to Calyx shareholders were duly passed. The number ofvotes for and against the resolutions were as follows: Shares Shareholders (either in person or by proxy) Number % Number %Resolution 1 - Ordinary ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 2 - Special ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 3 - Special ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 4 - Ordinary ResolutionFor 50,471,661 99.99% 48 98%Against 1,000 N/A 1 2% Resolution 5 - Simple Majority of votes cast by Independent Shareholders on a pollFor 30,333,923 99.9% 49 98%Against 1,000 N/A 1 2% The anticipated timeline of the remaining principal events required to implementthe Scheme is as follows: Intended Cancellation Record Time: 6.00 pm on 17 July 2007Intended date for Court Hearing (of the petition to sanction the 18 July 2007Scheme):Intended Transfer Record Time: 6.00 pm on 22 July 2007Last day of trading of Calyx Shares on AIM and IEX: 20 July 2007Intended Effective Date of the Scheme: 23 July 2007Dispatch of cheques/electronic settlements (as appropriate): No later than 6 August 2007 Capitalised terms in this announcement have the same meaning as in the SchemeDocument dated 8 June 2007. Enquiries: Calyx Group plc: +353 (0) 1 883 5555Gary Kennedy Davy Corporate Finance: +353 (0) 1 679 6363Financial Adviser to Calyx Group plcRonan GodfreyJohn Frain Murray Consultants: +353 (0) 1 498 0300Public Relations adviser to Calyx Group plcEd Micheau Deloitte Corporate Finance: +44 (0) 20 7936 3000Financial Adviser to Stornoway LimitedJonathan HintonDavid Smith Buchanan Communications: +44 (0) 20 7466 5000Public Relations adviser to Stornoway LimitedTim ThompsonJames Strong The Directors of Calyx accept responsibility for the information contained inthis announcement. To the best of their knowledge and belief (having taken allreasonable care to ensure that such is the case), the information contained inthis announcement for which they take responsibility is in accordance with thefacts and does not omit anything likely to affect the import of suchinformation. This announcement is not intended to and does not constitute an offer to sell orsubscribe for or an invitation to purchase or subscribe for any securities orthe solicitation of any vote or approval in any jurisdiction pursuant to theAcquisition or otherwise. Any response in relation to the Acquisition should bemade only on the basis of the information in the Scheme Document or any documentby which the Acquisition and Scheme are made. Davy Corporate Finance, which is authorised in Ireland by the FinancialRegulator under the Investment Intermediaries Act 1995, is acting exclusivelyfor Calyx and no-one else in connection with the Acquisition and will not beresponsible to anyone other than Calyx for providing the protections afforded toclients of Davy Corporate Finance or for providing advice in relation to theAcquisition. Deloitte Corporate Finance is acting exclusively for Stornoway and no-one elsein connection with the Acquisition and will not regard any other person as itsclient nor be responsible to anyone other than Stornoway for providing theprotections afforded to clients of Deloitte Corporate Finance nor for providingadvice in relation to the Acquisition, or any matter referred to in thisannouncement. Deloitte Corporate Finance is a division of Deloitte & Touche LLP,which is authorised and regulated by the Financial Services Authority in respectof regulated activities. The distribution of this announcement in or into certain jurisdictions may berestricted by the laws of those jurisdictions. Accordingly, copies of thisannouncement and all other documents relating to the Acquisition are not being,and must not be, mailed or otherwise forwarded, distributed or sent in, into orfrom any Restricted Jurisdiction. Persons receiving such documents (including,without limitation, nominees, trustees and custodians) should observe theserestrictions. Failure to do so may constitute a violation of the securities lawsof any such jurisdiction. Any person who is a holder of one per cent. or more of the Calyx Shares may havedisclosure obligations under Rule 8.3 of the Takeover Rules, effective from thedate of the commencement of the offer period in respect of the Acquisition. 2 July, 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Jun 20264:17 pmRNSLong-Term Incentive Plan Awards
1st Jun 20267:30 amRNSDirector Dealing
29th May 20263:00 pmRNSExercise of Options and Total Voting Rights
26th May 20267:00 amRNSFinal Results
14th May 20267:00 amRNSNotice of Presentations
13th Apr 20267:00 amRNSFY26 Trading Update and Notice of Results
30th Mar 20267:00 amRNSHolding(s) in Company
26th Nov 20257:30 amRNSDirector Dealing
18th Nov 20257:00 amRNSInterim Results
6th Nov 202511:30 amRNS-RCalnex and Viavi Partnership
30th Oct 20257:00 amRNSNotice of Results and Presentations
8th Oct 20252:08 pmRNSExercise of Options and Total Voting Rights
16th Sep 20259:09 amRNSExercise of Options and Total Voting Rights
14th Aug 20254:12 pmRNSResult of AGM
14th Aug 20257:00 amRNSAGM Statement
15th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
16th Jun 20259:52 amRNSLong-Term Incentive Plan Awards
10th Jun 202511:59 amRNSDirector Dealing
20th May 20257:00 amRNSFinal Results
15th May 20257:00 amRNSNotice of Investor Presentation
8th Apr 20257:00 amRNSFY25 Trading Update and Notice of Results
14th Mar 20257:00 amRNSDirector Dealing
29th Jan 202510:48 amRNSExercise of Options
19th Nov 20247:00 amRNSInterim Results
4th Nov 20247:00 amRNSNotice of Results and Investor Presentation
8th Oct 20247:00 amRNSDirector/PDMR Dealing
2nd Oct 20244:57 pmRNSResult of General Meeting
6th Sep 20247:00 amRNSNotice of General Meeting
22nd Aug 20245:18 pmRNSResult of AGM
22nd Aug 20247:00 amRNSAGM Statement
18th Jul 20249:08 amRNSNotice of AGM
17th Jul 20242:00 pmRNSLong-Term Incentive Plan Awards
21st May 20247:00 amRNSFY24 Final Results
10th Apr 20247:00 amRNSNotice of Investor Presentation
3rd Apr 20247:00 amRNSFY24 Trading Update and Notice of Results
21st Feb 20249:28 amRNSExercise of Options
14th Feb 20241:08 pmRNSExercise of Options
12th Dec 20233:47 pmRNSPDMR Dealings
21st Nov 20237:00 amRNSInterim Results
1st Nov 202312:24 pmRNSChange of Nominated Adviser
26th Oct 20237:00 amRNSNotice of Investor Presentation
10th Oct 20233:17 pmRNSTrading Update and Notice of Results
25th Aug 20234:36 pmRNSPDMR Dealings
16th Aug 20231:22 pmRNSResult of AGM
16th Aug 20237:00 amRNSAGM Statement
11th Aug 20232:00 pmRNSLong-Term Incentive Plan Awards
17th Jul 20237:00 amRNSNotice of AGM
12th Jul 202312:05 pmRNSDirector/PDMR Dealings
12th Jun 20234:34 pmRNSPDMR Dealings
23rd May 20237:00 amRNSFY23 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.